glp-1 and suicidal ideation receptor agonists risk of suicide or suicide attempts – A nationwide cohort and self-controlled case series study FDA clears GLP-1 medications of
Description
Meaningful appetite suppression typically begins at 5.0 mg, with significant weight loss acceleration happening at 10.0 mg and above
SOURCE Lemme

With a sip of water (no more than 4 ounces)

IQGAP1 binds AMPK and is required for maximum AMPK activation

If additional glycemic control is needed, the dose can be increased by 2.5 mg every 4 weeks, and the maximum dose of this drug is 15 mg once a week
10.1038/s41419-019-1904-7 43 YueW.LiY.OuD.YangQ